Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Microbot Medical Inc (MBOT)

Microbot Medical Inc (MBOT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,994
  • Shares Outstanding, K 4,308
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,240 K
  • 60-Month Beta 4.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.39
  • Number of Estimates 1
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.72
  • Growth Rate Est. (year over year) +45.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.50 +44.44%
on 11/20/19
6.68 -2.69%
on 12/10/19
+1.56 (+31.60%)
since 11/08/19
3-Month
4.50 +44.44%
on 11/20/19
7.00 -7.14%
on 09/11/19
+0.10 (+1.56%)
since 09/10/19
52-Week
1.38 +371.01%
on 12/18/18
19.40 -66.49%
on 01/15/19
+4.55 (+233.33%)
since 12/10/18

Most Recent Stories

More News
Global Jurisdictions Continue to Recognize Microbot Medical's Innovative Technology; Receives Notice of Allowance for a U.S. Patent Covering its TipCAT(TM) Technology Platform

Further demonstrating its commitment to expand and protect its Intellectual Property (IP) portfolio, Microbot Medical Inc. (Nasdaq: MBOT) was issued a Notice of Allowance for patent application No. 15/936,878...

MBOT : 6.50 (+16.70%)
Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT(TM) Technology Platform

In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application...

MBOT : 6.50 (+16.70%)
Microbot Medical Announces Outcome of Annual Meeting of Shareholders

Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS)

MBOT : 6.50 (+16.70%)
Microbot Medical's Self-Cleaning Shunt (SCS(TM)) Clearly Demonstrated the Ability to Prevent Shunt Occlusion in a Follow-up In-vitro Laboratory Study

Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational effectiveness of Microbot Medical Inc.'s (NASDAQ: MBOT) Self-Cleaning...

MBOT : 6.50 (+16.70%)
Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference

At the upcoming Rodman & Renshaw Global Investment Conference, Harel Gadot, CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will demonstrate a working prototype of the Company's Self-Cleaning...

MBOT : 6.50 (+16.70%)
Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis

As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance from the Israel Intellectual Property...

MBOT : 6.50 (+16.70%)
Report: Developing Opportunities within Lockheed Martin, Arlo Technologies, Microbot Medical, and Aytu Bioscience -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Lockheed Martin Corporation (NYSE:LMT),...

AYTUD : 4.1000 (+3.80%)
LMT : 384.44 (+0.29%)
ARLO : 3.15 (-3.37%)
MBOT : 6.50 (+16.70%)
AYTU : 0.69 (+3.23%)
Microbot Medical Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System

As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian...

MBOT : 6.50 (+16.70%)
Microbot Medical Maintains 2019 Milestone Targets Following Recent Court Decision

Microbot Medical Inc. (Nasdaq CM: MBOT) is maintaining its milestone targets for 2019 following the recently announced decision of the New York State Supreme Court to rescind the Stock Purchase Agreement...

MBOT : 6.50 (+16.70%)
Thinking about buying stock in American Airlines, Boxlight Corp, Microbot Medical, Pier 1 Imports or Snap Inc.?

InvestorsObserver issues critical PriceWatch Alerts for AAL, BOXL, MBOT, PIR, and SNAP.

AAL : 27.00 (-1.78%)
MBOT : 6.50 (+16.70%)
PIR : 7.72 (+1.18%)
SNAP : 14.09 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade MBOT with:

Business Summary

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable...

See More

Key Turning Points

2nd Resistance Point 7.49
1st Resistance Point 7.00
Last Price 6.50
1st Support Level 5.69
2nd Support Level 4.87

See More

52-Week High 19.40
Fibonacci 61.8% 12.52
Fibonacci 50% 10.39
Fibonacci 38.2% 8.26
Last Price 6.50
52-Week Low 1.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar